Clinical Trial Update: The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating liraglutide as an adjunct to insulin in Type 1 diabetes mellitus, reporting on efficacy and safety. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Liraglutide (Victoza) (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2017-03-06